Loss of heterozygosity (LOH), malignancy grade and clonality in microdissected prostate cancer
1999
Prostate Cancer and Loss of Heterozygosity
Sample size: 47
publication
Evidence: moderate
Author Information
Author(s): Hügel A, Wernert N
Primary Institution: Institute of Pathology, University of Bonn
Hypothesis
Does increasing malignancy of prostate carcinoma correlate with an overall increase of loss of heterozygosity (LOH)?
Conclusion
The study found that higher malignancy grades in prostate cancer are associated with increased loss of heterozygosity.
Supporting Evidence
- The overall LOH rate was significantly lower in grade 1 areas compared to grades 2 and 3.
- A similar trend was observed for the mean fractional allele loss across the grades.
- 65% of tumors with LOH in several areas showed identical losses at multiple loci, indicating clonal development.
Takeaway
This study looked at prostate cancer and found that as the cancer gets worse, it loses more genetic information.
Methodology
The study analyzed 47 prostate carcinomas at 25 chromosomal loci to assess LOH rates.
Statistical Information
P-Value
0.0004
Statistical Significance
p=0.007
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website